LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 82.75 | 84.90 | 6274 | 8621 | 0.7277 | 0.9069 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 82.75 | 84.90 | 8947 | 8621 | 1.0378 | 1.0111 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 84.45 | 84.90 | 857 | 8254 | 0.1038 | 0.4192 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 84.45 | 84.90 | 10262 | 8254 | 1.2432 | 1.0670 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 84.45 | 84.90 | 4902 | 8254 | 0.5938 | 0.8482 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 84.45 | 84.90 | 9093 | 8254 | 1.1015 | 1.0295 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 86.16 | 84.90 | 868 | 8141 | 0.1066 | 0.4235 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 86.16 | 84.90 | 10476 | 8141 | 1.2867 | 1.0781 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 86.16 | 84.90 | 3500 | 8141 | 0.4299 | 0.7593 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 86.16 | 84.90 | 9205 | 8141 | 1.1306 | 1.0376 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 87.86 | 84.90 | 817 | 7680 | 0.1064 | 0.4168 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 87.86 | 84.90 | 10652 | 7680 | 1.3869 | 1.1032 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 87.86 | 84.90 | 2751 | 7680 | 0.3582 | 0.7078 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 87.86 | 84.90 | 9348 | 7680 | 1.2171 | 1.0614 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 89.57 | 84.90 | 824 | 7494 | 0.1100 | 0.4213 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 89.57 | 84.90 | 10913 | 7494 | 1.4561 | 1.1197 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 89.57 | 84.90 | 2234 | 7494 | 0.2981 | 0.6585 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 89.57 | 84.90 | 9448 | 7494 | 1.2606 | 1.0730 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 91.27 | 84.90 | 789 | 7420 | 0.1063 | 0.4129 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 91.27 | 84.90 | 11162 | 7420 | 1.5043 | 1.1307 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 91.27 | 84.90 | 1703 | 7420 | 0.2295 | 0.5919 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 91.27 | 84.90 | 9571 | 7420 | 1.2899 | 1.0805 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 92.98 | 84.90 | 846 | 7257 | 0.1166 | 0.4308 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 92.98 | 84.90 | 11366 | 7257 | 1.5661 | 1.1448 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 92.98 | 84.90 | 1328 | 7257 | 0.1830 | 0.5350 | MN20160318_Q02 | N08 |